Amyloidosis
Updates to Article Attributes
Amyloidosis is a heterogeneous disease, or even considered a constellation of diseases, resulting in athe deposition of relatively similar proteins. It has many causes and can affect essentially any organ system.
Epidemiology
There may be male predilection. Typically affects middle-aged individuals around 60 years 5.
Pathology
Amyloid comprises a group of proteins characterised by certain physical properties. There are at least 15 amyloid proteins are derived, derived from diverse precursors. Some demonstrate structural morphology of immunoglobulins (amyloid light chain).
Subtypes
- primary amyloidosis: associated with monoclonal plasma cell dyscrasias
- secondary amyloidosis: usually occurs secondary to a tissue destructive and inflammatory process
- hereditary amyloidosis: can be seen with familial Mediterranean fever (FMF)
- senile amyloidosis
- localised amyloidosis: sometimes classified as a separate entity with the above four accounting for the systemic forms
In certain scenarios, the amyloid proteins are produced and deposited locally, whereas in others, the protein is distributed systemically.
Systemic amyloidosis
The majority occur in the systemic form:
- AL (amyloid light chain)
- synthesised by plasma cells, and seen in conditions with monoclonal proliferation of these cells
- AA (amyloid associated)
- derived from SAA (serum
associated amyloid-associatedamyloid A) protein which is synthesised by the liver and forms part of the HDL3 lipoproteins - typically seen in chronic inflammatory disease or familial Mediterranean fever
- derived from SAA (serum
- Aß2M
:(amyloid ß2-microglobulin)- derived from ß2-microglobulin
, and - seen in patients on haemodialysis
- derived from ß2-microglobulin
- ATTR
(amyloidtranthyretin(amyloid transthyretin)- seen in senile systemic amyloidosis / neuropathic cerebral angiopathy
- is the most common form of familial amyloidosis 5
Localised amyloidosis
Accounts for ≈15% of amyloidosis:
- A4ß2 (beta-amyloid protein): seen in Alzheimer disease
- AANF (atrial natriuretic factor): isolated atrial amyloidosis
- AIAPP (islet amyloid peptide): deposited in the pancreas in patients with type II diabetes mellitus
- ACal: seen in medullary islet cell tumour
Organ-specific amyloidosis
Amyloid deposition can occur in essentially any part of the body, although some are more common and have specific imaging findings. These conditions are best discussed separately:
- breast amyloidosis
- cardiac amyloidosis
- cerebral amyloid deposition diseases
- gastrointestinal amyloidosis
- hepatic amyloidosis
- pulmonary amyloidosis
- renal amyloidosis
- skeletal amyloidosis
- splenic amyloidosis
- tracheobronchial amyloidosis
- urinary tract amyloidosis
Histology
Amyloid is an insoluble extracellular proteinaceous substance composed of cross-ß-pleated sheets which display apple-green birefringence when viewed under polarised light after being treated with Congo red stain 1.
Associations
- multiple myeloma (with primary amyloidosis)
-<p><strong>Amyloidosis </strong>is a heterogeneous disease or even considered a constellation of diseases resulting in a deposition relatively similar proteins. It has many causes and can affect essentially any organ system.</p><h4>Epidemiology </h4><p>There may be male predilection. Typically affects middle-aged individuals around 60 years <sup>5</sup>.</p><h4>Pathology</h4><p>Amyloid comprises a group of proteins characterised by certain physical properties. There are at least 15 amyloid proteins are derived from diverse precursors. Some demonstrate structural morphology of immunoglobulins (amyloid light chain).</p><h5>Subtypes</h5><ul>- +<p><strong>Amyloidosis </strong>is a heterogeneous disease, or even considered a constellation of diseases, resulting in the deposition of relatively similar proteins. It has many causes and can affect essentially any organ system.</p><h4>Epidemiology </h4><p>There may be male predilection. Typically affects middle-aged individuals around 60 years <sup>5</sup>.</p><h4>Pathology</h4><p>Amyloid comprises a group of proteins characterised by certain physical properties. There are at least 15 amyloid proteins, derived from diverse precursors. Some demonstrate structural morphology of immunoglobulins (amyloid light chain).</p><h5>Subtypes</h5><ul>
-</ul><p>In certain scenarios, the amyloid proteins are produced and deposited locally, whereas in others the protein is distributed systemically. </p><h6>Systemic amyloidosis</h6><p>The majority occur in the systemic form:</p><ul>- +</ul><p>In certain scenarios, the amyloid proteins are produced and deposited locally, whereas in others, the protein is distributed systemically. </p><h6>Systemic amyloidosis</h6><p>The majority occur in the systemic form:</p><ul>
-<li>derived from SAA (serum associated amyloid-associated) protein which is synthesised by the liver and forms part of the HDL3 lipoproteins</li>- +<li>derived from SAA (serum amyloid A) protein which is synthesised by the liver and forms part of the HDL3 lipoproteins</li>
-<li>Aß<sub>2</sub>M: derived from ß<sub>2</sub>-microglobulin, and seen in patients on haemodialysis</li>-<li>ATTR (amyloidtranthyretin)<ul>- +<li>Aß<sub>2</sub>M (amyloid ß<sub>2</sub>-microglobulin)<ul>
- +<li>derived from ß<sub>2</sub>-microglobulin</li>
- +<li>seen in patients on haemodialysis</li>
- +</ul>
- +</li>
- +<li>ATTR (amyloid transthyretin)<ul>